Results 31 to 40 of about 212,540 (258)

Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion [PDF]

open access: yes, 2013
Purpose: To assess the levels of inflammatory and angiogenic cytokines in undiluted vitreous from treatment-naïve patients with macular edema secondary to nonischemic branch retinal vein occlusion (BRVO), with flow cytometric bead array (CBA) and to ...
Michaelis, Martin   +8 more
core   +1 more source

MACULAR EDEMA AFTER CATARACT PHACOEMULSIFICATION IN DIABETIC RETINOPATHY AND TYPE 2 DIABETES MELLITUS

open access: yesМедична наука України
Background. One of the complications of diabetes mellitus is diabetic cataract, which may occur in combination with age-related cataract. Phacoemulsification of cataract with intraocular lens implantation is the gold standard for cataract treatment ...
Olesya Horokhivska
doaj   +1 more source

A Prospective Study of Safety Profile and Efficacy of three doses of Intravitreal Bevacizumab in Diabetic Macular Edema

open access: yesIJRETINA (International Journal of Retina), 2021
Introduction: Current study aimed to evaluate efficacy of intravitreal Bevacizumab in Diabetic macular edema, and to identify their ocular and systemic complications if any.
Nasrin Y, Sharma Ajay, Sharmila Yalakala
doaj   +1 more source

Corticosteroid Treatment in Diabetic Macular Edema [PDF]

open access: yes, 2017
Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial.
Burcu Nurözler Tabakcı, Nurten Ünlü
core   +1 more source

One day wonder: Fast resolution of macular edema following intravitreal ranibizumab in retinal venous occlusions

open access: yesIndian Journal of Ophthalmology, 2013
Macular edema is a significant cause of vision loss in patients with central retinal vein occlusions and branch retinal vein occlusions. Vascular endothelial growth factor (VEGF) appears to be a key factor in the pathogenesis of this disease.
Lalit Verma   +3 more
doaj   +1 more source

A case of bilateral cystoid macular edema after rituximab infusion

open access: yesIndian Journal of Ophthalmology. Case Reports, 2022
A 65-year-old man experienced sudden bilateral vision loss after rituximab infusion. Best corrected visual acuity was 1/10, and cystoid macular edema was identified.
Alexandros Rouvas   +2 more
doaj   +1 more source

The macular edema

open access: yesNepalese Journal of Ophthalmology, 1970
DOI: http://dx.doi.org/10.3126/nepjoph.v3i2.5259   Nepal J Ophthalmol 2011; 3(2): 99 ...
openaire   +3 more sources

Inhibition of VEGF‐Induced Angiogenesis and Vascular Leakage by Bicistronic Co‐Expression of Aflibercept and COMP‐Ang1

open access: yesAdvanced Healthcare Materials, EarlyView.
A bicistronic rAAV8 vector encoding Aflibercept (Afb) and COMP‐cAng1 simultaneously coordinates VEGF clearance and Tie2‐mediated vessel maturation. In a 3D angiogenesis‐on‐a‐chip model, rAAV8‐Afb/cAng1 effectively reverses pathological barrier breakdown under clinical disease‐mimicking challenges.
Bong‐Kyu Kim   +9 more
wiley   +1 more source

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions

open access: yesActa Biomedica Scientifica, 2020
Background. Macular edema is considered as a risk factor for a significant decrease in the visual acuity and quality of life of the patient, regardless of its cause.
A. G. Shchuko   +3 more
doaj   +1 more source

3D‐Printed Corneal Substitutes: Materials, Fabrication, and Preclinical Progress

open access: yesAdvanced Materials Technologies, EarlyView.
Successful clinical translation of 3D‐printed corneal substitutes relies on the interplay between the bioink properties, cellular component, and the fabrication process. These factors influence the critical properties of the construct, including optical transparency, mechanical stability, suture retention, that ultimately govern long‐term stromal ...
Shadi Moshayedi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy